Spherix (SPEX) Drives Deep Into Positive Zone; Monsanto (MON) “Not Enough” Bayer’s Offer

Spherix_SPEX

Spherix Inc. (Nasdaq:SPEX) shares skyrocketed 145.5% to touch the $4.69 mark in intraday trading Tuesday as the company said that it has reached a second licensing deal with patent risk management solutions provider RPX Corp. (Nasdaq:RPXC).

SPEX stock is trading at $3.18, up $1.27 (or +66.36%), and 11,535,719 of its shares exchanged hands so far, representing a large increase in activity versus its average volume (3m) of 123,700

Spherix, an intellectual property development company, has 48.26M Shares Outstanding, and SPEX stock 52-week range is from $1.52 to $13.11 per share

*

Monsanto_MON

Shares of Monsanto Co. (NYSE:MON) surged on Tuesday’s trading session after the company spurned a $62 billion takeover offer from Bayer AG (OTCMKTS:BAYRY), saying the bid significantly undervalues its business, but adding that it is open to further talks with the German firm.

MON stock is exchanging hands at $108.87, up $2.87 (or +2.71%), and 16,627,612 of its shares were traded so far

Monsanto, which provides agricultural products for farmers worldwide, has 436.84M Shares Outstanding and MON stock one-year range is between $81.22 and $120.00 per share

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/